Detroit Karmanos center unveils new device for treating liver cancer at home
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
Liver Metastasis Treatment Market to Reach US$ 3.3 Billion, Growing at 6.5% CAGR by 2034 | Fact.MR Report
Growing demand for sophisticated and personalized treatment options to cure liver metastasis is expected to boost the market.Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...
Healthline13d
Symptoms of Late Stage Metastatic Breast Cancer
Treatment for metastatic breast cancer varies depending on where the ... Metastases in the lungs, brain, bones, or liver might each cause different symptoms. Becoming familiar with these symptoms ...
Hosted on MSN10d
Researchers link foodborne toxin to colorectal cancer metastasis
Metastases, or secondary growths formed away from the initial cancer site, are the primary cause of death from cancer, and ...
Business Wire8d
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...
News Medical on MSN12d
Extracellular vesicle DNA regulates immune responses and suppresses liver metastasis
The study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal ...
The American Journal of Managed Care5d
Treatment Combinations Based in Immune Checkpoint Inhibitors Provide Survival Benefits in CRC
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
Managed Healthcare Executive5d
Two New FDA Approvals in Lung Cancer
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Taiwan News11h
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer - REDWOOD ... (bev) in treatment naïve patients with ...